Clinical Trials as a Safety Net: What to Do When Your Drug Is Denied and Nothing Else Works
Clinical Trials as a Safety Net: What to Do When Your Drug Is Denied and Nothing Else Works
6 minute read
You have appealed. You have submitted documentation. Your doctor has written letters, made calls, requested peer-to-peer reviews. And the answer is still no. It is a position nobody should have to be in, and yet it is real for a meaningful number of people every year.
When standard coverage channels are closed, there are options that most people never hear about: clinical trials, compassionate use programs, and expanded access pathways that can provide access to medications that would otherwise be out of reach. These are not long shots. They are legitimate, federally regulated access pathways that exist precisely for situations where the normal system has failed.
What Clinical Trials Can Actually Offer
The phrase "clinical trial" tends to conjure an image of experimental risk: a patient agreeing to be a guinea pig for an untested drug. That image is outdated and, in many cases, inaccurate.
Many clinical trials are studying drugs that already have substantial evidence behind them. Late-phase (Phase III) trials are often studying drugs that are already approved in other countries or for other indications, or drugs that are seeking expanded FDA approval. Participating in a Phase III trial may give you access to a medication that is already considered the standard of care in a different context.
The practical benefits of a clinical trial for someone whose drug has been denied can include:
The tradeoffs are real: trials have eligibility criteria that may or may not fit your situation, you may be randomized to a comparator arm, and participation requires regular study visits. But for someone who has been denied access to a medication and has no other path, these tradeoffs are worth understanding.
How to Find Clinical Trials: ClinicalTrials.gov Walkthrough
ClinicalTrials.gov is the federal registry for clinical research studies in the United States and globally. As of 2024, it lists more than 450,000 registered studies.¹ Navigating it without guidance can feel overwhelming, but the search is more manageable than it looks.
Here is a practical path through the database:
Step 1: Go to clinicaltrials.gov and click "Find a Study."
Step 2: Enter your condition in the "Condition or disease" field. Use the medical name your doctor uses (for example, "rheumatoid arthritis" rather than "joint pain") to get the most relevant results.
Step 3: If you are looking for a specific drug, enter the drug name in the "Other terms" field. This will filter for trials specifically studying that medication.
Step 4: Set your location. You can search by country, state, city, or distance from your zip code. Many trials have multiple sites, and one may be closer than you expect.
Step 5: Filter by study status. Set the status to "Recruiting" to see only trials that are actively enrolling participants.
Step 6: Review the eligibility criteria carefully. Each trial lists inclusion and exclusion criteria. These define who qualifies to participate. Reading these carefully before contacting a study site will save time for both you and the research team.
Step 7: Contact the study team. Each trial listing includes contact information. A research coordinator can walk you through the screening process and tell you whether you might qualify.
Your physician can also search on your behalf and may be aware of trials at their institution or at academic medical centers in your region.
Compassionate Use and Expanded Access
If you need a drug that is still in early clinical trials and not yet widely accessible, the FDA's expanded access (compassionate use) program may be an option. This pathway allows patients with serious or life-threatening conditions to access investigational drugs outside of a clinical trial when no comparable alternatives exist.
Expanded access requires:
The process begins with your physician, who submits an expanded access request to both the FDA and the drug manufacturer. Manufacturers are not required to grant expanded access requests, though many do. The FDA's goal is to respond to individual patient expanded access requests within a few days in urgent situations.
If you are facing a situation where your medication has been denied, no alternative is clinically appropriate, and an investigational drug may help, this is a conversation to have with your physician directly. The expanded access pathway is underused relative to the number of patients who might benefit from it.
Patient Advocacy Organizations as a Bridge
Disease-specific patient advocacy organizations often maintain current knowledge of both open clinical trials and manufacturer patient assistance programs for denied medications. For conditions like multiple sclerosis, rheumatoid arthritis, rare diseases, and certain cancers, these organizations have staff whose specific job is helping patients navigate access barriers.
A few organizations with robust patient navigation programs include:
These organizations do not charge patients for navigation services. They are often the fastest path to someone who has helped other people in exactly your situation.
What This Means for You
If you are at the point where you have tried everything the standard appeals process offers, clinical trials and expanded access pathways are worth exploring seriously. They are not desperate measures. They are a legitimate part of the healthcare system designed for exactly these moments.
Ellen can help you identify your options and understand which access pathways may be relevant to your situation. Start here →
Frequently Asked Questions
Do I have to pay to participate in a clinical trial?
No. Clinical trial participants do not pay for the study drug or for study-related procedures. You may have costs related to travel, lodging if the trial site is far from home, or care that is not covered by the study protocol but that you would have needed anyway. Some trials offer travel reimbursement. Ask the study coordinator about cost coverage when you make initial contact.
How do I know if a clinical trial is legitimate?
All legitimate clinical trials conducted in the United States are required to be registered on ClinicalTrials.gov. Legitimate trials also have Institutional Review Board (IRB) approval, which provides an independent ethics review of the study protocol. You should receive a detailed informed consent document before enrolling, and you have the right to withdraw from a trial at any time.
What is the difference between expanded access and a clinical trial?
A clinical trial is a research study designed to generate scientific evidence about a drug's safety and effectiveness. You may be randomized to a placebo or comparator group. Expanded access (compassionate use) is an individual access pathway outside of a trial, for a specific patient who needs a drug and has no other options. In expanded access, you receive the drug being requested (not a placebo), but you are also not part of a research study generating generalizable evidence.
Sources: